Levofloxacin

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Chemotherapy drug, gyrase inhibitor.

Spectrum of actionThis section has been translated automatically.

see below Ofloxacin.

IndicationThis section has been translated automatically.

Ambulantly acquired pneumonia, complete urinary tract infections, skin and soft tissue infections, acute sinusitis, acute exacerbation of chronic bronchitis.

Limited indicationThis section has been translated automatically.

Severe pneumococcal pneumonia, simultaneous treatment with NSAIDs or theophylline, avoid treatment with UV light, patients with G6PDH deficiency

Dosage and method of useThis section has been translated automatically.

For skin and soft tissue infections 250 mg once/day or 500 mg 1-2 times/day p.o.

Note! Elimination in patients with liver cirrhosis reduced, dose reduction!

Standard concentrationThis section has been translated automatically.

5 mg/ml in eye drops.

Undesirable effectsThis section has been translated automatically.

S.u. Ofloxacin.

ContraindicationThis section has been translated automatically.

Pregnancy, nursing.

PreparationsThis section has been translated automatically.

Tavanic, Oftaquix eye drops

Authors

Last updated on: 29.10.2020